The lncrna HMMR-AS1 promotes the malignant progression of ovarian cancer cells by regulating the miR-627-3p/PTN axis
In summary, HMMR-AS1 is highly expressed in ovarian cancer and plays a carcinogenic role by regulating the miR-627-3p/PTN axis and suggest that targeting HMMR-AS1 is a potential strategy for ovarian cancer treatment.
Authors
- Jinhua He (ORCID: https://orcid.org/0000-0001-8081-2364)
- Zhaoping Chu
- Jie Li (ORCID: https://orcid.org/0000-0003-0973-8645)
- Yunxia Zhang (ORCID: https://orcid.org/0000-0002-5637-6782)
- Fei Tian (ORCID: https://orcid.org/0000-0002-3302-1970)
Institutions
- North China University of Science and Technology (CN)
- Hebei General Hospital (CN)
Publication Details
- Journal
- Journal of Ovarian Research
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1186/s13048-025-01691-6
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.94